Jeffrey Bassett on Muck Rack

Jeffrey Bassett

As seen in: Radiological Society of North America

Get in touch with Jeffrey

Contact Jeffrey , search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Jeffrey Bassett’s Journalist Portfolio

See all →
The Willingness to Serve by Dr. Richard Isaacs, MD

The Willingness to Serve by Dr. Richard Isaacs, MD

In the modern world, the desire or the willingness to help others solve their problems is not complete withou…

View article →
Yuuby | Jeffrey Bassett's Note "At your service by D..."

Yuuby | Jeffrey Bassett's Note "At your service by D..."

Jeffrey Bassett is on Yuuby. Join the conversation, find out what Jeffrey Bassett is doing and liking!

View article →
Dr. Howard Marans: Your most trusted orthopedic health partner for life

Dr. Howard Marans: Your most trusted orthopedic health partner for life

As soon as you enter the office of Dr. Howard Marans, you’re going to feel a transforming and healing prese…

View article →
Medical Profile of Dr. Richard Isaacs

Medical Profile of Dr. Richard Isaacs

SUMMARY Professional Background "I joined Kaiser Permanente in 1995 and have Advanced Certification in Head a…

View article →
Hill & Associates Ltd Hong Kong, Security Risk Management

Hill & Associates Ltd Hong Kong, Security Risk Management

Hill & Associates Business continuity with full-spectrum problem solving. We don't make headlines. We make s…

View article →
Different Lawyer Types In Singapore

Different Lawyer Types In Singapore

Singapore is home to one of the best education systems in the world. Its high education level enables bright,…

View article →

Articles

18F-DCFPyL PET/CT for Initially Diagnosed and Biochemically Recurrent Prostate Cancer: Prospective Trial with Pathologic Confirmation

|
By Gary A. Ulaner, Jeffrey Bassett, Beth Thomsen, Robert Torrey
| Radiological Society of North America
This prospective clinical trial demonstrated with histologic examination the high positive predictive value of 2-(3-{1-carboxy-5-[(6-[(18)F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid PET/CT for prostate cancer distant metastases and recurrences and identified sites of false-positive findings. Background Prostate-specific membrane antigen (PSMA) PET is standard for newly diagnosed high-risk and biochemically recurrent (BCR) prostate cancer.
Open in Who Shared Issue with article?
See all 1 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified